Clinical Trial Update: Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating decolonization strategies for patients colonized with ESBL-producing Enterobacteriaceae. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterobacteriaceae Infections

Snippet

Sponsor: University Hospital, Geneva | Conditions: Enterobacteriaceae Infections | Phase 4 | Status: COMPLETED